© Copyright BKNINJA. All Rights Reserved.
Wednesday, February 4
Header Banner
Home›Health›Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
Health

Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

cryptomagazine
January 5, 2026
0
4

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.

Previous Article

XRP’s 9% surge leads crypto as bitcoin climbs to 6-week high near ...

Next Article

Polymarket Trader’s $400K Bet on Maduro’s Ousting Sparks Insider Trading Controversy

Leave a reply

More News

About Us

The Rubik theme is the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. It’s never been easier to build a standout website.

© Copyright BKNINJA. All Rights Reserved.